• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆肠内酯、染料木黄酮与绝经前乳腺癌风险

Plasma enterolactone and genistein and the risk of premenopausal breast cancer.

作者信息

Piller Regina, Chang-Claude Jenny, Linseisen Jakob

机构信息

Unit of Human Nutrition and Cancer Prevention, Technical University of Munich, and German Cancer Research Center, Department of Clinical Epidemiology, Heidelberg, Germany.

出版信息

Eur J Cancer Prev. 2006 Jun;15(3):225-32. doi: 10.1097/01.cej.0000197449.56862.75.

DOI:10.1097/01.cej.0000197449.56862.75
PMID:16679865
Abstract

BACKGROUND

The scientific debate on the role of dietary phytoestrogens for prevention of breast cancer is still ongoing. We previously reported an inverse association between dietary phytoestrogen intake and premenopausal breast cancer risk and now examine the relationship with plasma phytoestrogen concentrations.

METHODS

We measured enterolactone (mammalian lignan) and genistein (isoflavone) concentrations in plasma samples of 220 premenopausal cases and 237 age-matched controls from a population-based case-control study in Germany.

RESULTS

Median plasma enterolactone concentrations in cases and controls were 6.3 and 9.7 nmol/l, respectively, and median genistein concentrations were 4.5 and 3.7 nmol/l, respectively. Premenopausal breast cancer risk decreased with increasing plasma enterolactone concentrations. Adjusted odds ratios (95% confidence intervals) were 0.42 (0.20-0.90) and 0.38 (0.17-0.85) (P for trend 0.007) for women in the third and fourth quartile of plasma enterolactone compared to those in the lowest quartile. There was no significant association between plasma genistein concentration and premenopausal breast cancer risk.

CONCLUSION

Using biomarkers of phytoestrogen intake, we confirmed the strong inverse association between enterolactone and premenopausal breast cancer risk as found with dietary intake estimates. This result gives support to the potential role of mammalian lignans for breast cancer prevention among premenopausal women in Western populations.

摘要

背景

关于膳食植物雌激素在预防乳腺癌中作用的科学争论仍在继续。我们之前报道了膳食植物雌激素摄入量与绝经前乳腺癌风险之间的负相关关系,现在研究其与血浆植物雌激素浓度的关系。

方法

在德国一项基于人群的病例对照研究中,我们测量了220例绝经前病例和237例年龄匹配对照的血浆样本中肠内酯(哺乳动物木脂素)和染料木黄酮(异黄酮)的浓度。

结果

病例组和对照组血浆肠内酯浓度中位数分别为6.3和9.7 nmol/l,染料木黄酮浓度中位数分别为4.5和3.7 nmol/l。绝经前乳腺癌风险随血浆肠内酯浓度升高而降低。与血浆肠内酯最低四分位数组相比,第三和第四四分位数组女性的调整优势比(95%置信区间)分别为0.42(0.20 - 0.90)和0.38(0.17 - 0.85)(趋势P值为0.007)。血浆染料木黄酮浓度与绝经前乳腺癌风险之间无显著关联。

结论

通过使用植物雌激素摄入量的生物标志物,我们证实了肠内酯与绝经前乳腺癌风险之间存在如膳食摄入量估计所发现的强烈负相关关系。这一结果支持了哺乳动物木脂素在西方人群绝经前女性预防乳腺癌中的潜在作用。

相似文献

1
Plasma enterolactone and genistein and the risk of premenopausal breast cancer.血浆肠内酯、染料木黄酮与绝经前乳腺癌风险
Eur J Cancer Prev. 2006 Jun;15(3):225-32. doi: 10.1097/01.cej.0000197449.56862.75.
2
Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.血清肠内酯与乳腺癌风险:芬兰东部的一项病例对照研究
Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):339-44.
3
An incident case-referent study on plasma enterolactone and breast cancer risk.一项关于血浆肠内酯与乳腺癌风险的病例对照研究。
Eur J Nutr. 2002 Aug;41(4):168-76. doi: 10.1007/s00394-002-0373-3.
4
Urinary phytoestrogens and postmenopausal breast cancer risk.尿中植物雌激素与绝经后乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):223-8.
5
Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).膳食植物雌激素、血清肠内酯与前列腺癌风险:瑞典前列腺癌研究(瑞典)
Cancer Causes Control. 2006 Mar;17(2):169-80. doi: 10.1007/s10552-005-0342-2.
6
Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.日本女性血浆异黄酮水平与乳腺癌发病风险:来自日本公共卫生中心前瞻性研究组的巢式病例对照研究
J Clin Oncol. 2008 Apr 1;26(10):1677-83. doi: 10.1200/JCO.2007.13.9964. Epub 2008 Mar 3.
7
Plasma enterolactone and breast cancer incidence by estrogen receptor status.按雌激素受体状态划分的血浆肠内酯与乳腺癌发病率
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2084-9.
8
CYP17 genotype modifies the association between lignan supply and premenopausal breast cancer risk in humans.细胞色素P450 17α-羟化酶/17,20-裂解酶(CYP17)基因分型改变了人体内木脂素摄入量与绝经前乳腺癌风险之间的关联。
J Nutr. 2006 Jun;136(6):1596-603. doi: 10.1093/jn/136.6.1596.
9
Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.两年期间血清木脂素和异黄酮类植物雌激素测量的可靠性。
Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):885-9.
10
Enterolactone as a risk factor for breast cancer: a review of the published evidence.肠内酯作为乳腺癌的一个风险因素:已发表证据的综述
Clin Chim Acta. 2006 Mar;365(1-2):58-67. doi: 10.1016/j.cca.2005.07.026. Epub 2005 Sep 15.

引用本文的文献

1
Lignan exposure: a worldwide perspective.木质素暴露:全球视角。
Eur J Nutr. 2022 Apr;61(3):1143-1165. doi: 10.1007/s00394-021-02736-4. Epub 2021 Nov 20.
2
Flaxseed oil stimulates gynecomastia.亚麻籽油可刺激乳腺发育。
BMJ Case Rep. 2020 Dec 10;13(12):e237948. doi: 10.1136/bcr-2020-237948.
3
Impact of lignans in oilseed mix on gut microbiome composition and enterolignan production in younger healthy and premenopausal women: an in vitro pilot study.油籽混合物中木脂素对年轻健康和绝经前女性肠道微生物组组成和肠内木脂素产生的影响:一项体外初步研究。
Microb Cell Fact. 2020 Apr 3;19(1):82. doi: 10.1186/s12934-020-01341-0.
4
Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans.解释人体血浆肠内酯浓度人际差异的因素。
Mol Nutr Food Res. 2019 Aug;63(16):e1801159. doi: 10.1002/mnfr.201801159. Epub 2019 Mar 26.
5
Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.肠内酯的抗癌和抗转移潜力:临床、临床前和机制观点。
Eur J Pharmacol. 2019 Jun 5;852:107-124. doi: 10.1016/j.ejphar.2019.02.022. Epub 2019 Feb 14.
6
Biomarkers of Dietary Polyphenols in Cancer Studies: Current Evidence and Beyond.癌症研究中膳食多酚的生物标志物:当前证据及其他。
Oxid Med Cell Longev. 2015;2015:732302. doi: 10.1155/2015/732302. Epub 2015 Jun 9.
7
Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study.植物木脂素7-羟基matairesinol的药代动力学和生物利用度及其对绝经后妇女血清肠内酯和临床症状的影响:一项单盲、平行、剂量比较研究。
J Am Coll Nutr. 2013;32(6):428-35. doi: 10.1080/07315724.2013.849578.
8
S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.在接受医生建议的乳房活检的低异黄酮摄入的美国绝经后女性中,S-(-)雌马酚产生状态与乳腺癌风险无关。
Nutr Res. 2014 Feb;34(2):116-25. doi: 10.1016/j.nutres.2013.12.002. Epub 2013 Dec 18.
9
Soy, red clover, and isoflavones and breast cancer: a systematic review.大豆、红三叶草和异黄酮与乳腺癌:系统评价。
PLoS One. 2013 Nov 28;8(11):e81968. doi: 10.1371/journal.pone.0081968. eCollection 2013.
10
Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.血浆肠内酯与护士健康研究 II 中的乳腺癌风险。
Breast Cancer Res Treat. 2013 Jun;139(3):801-9. doi: 10.1007/s10549-013-2586-y. Epub 2013 Jun 13.